<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Researcher on Reputo | Career Guide + Study Tools for Students</title><link>https://reputo.net/en/jobs/researcher/</link><description>Recent content in Researcher on Reputo | Career Guide + Study Tools for Students</description><generator>Hugo</generator><language>en</language><lastBuildDate>Tue, 21 Jul 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://reputo.net/en/jobs/researcher/index.xml" rel="self" type="application/rss+xml"/><item><title>Industry AI Lab Researcher: Crossing From Academia to a Frontier Lab</title><link>https://reputo.net/en/jobs/researcher/specializations/industry-ai-lab-transition/</link><pubDate>Tue, 21 Jul 2026 00:00:00 +0000</pubDate><guid>https://reputo.net/en/jobs/researcher/specializations/industry-ai-lab-transition/</guid><description>&lt;h2 id="why-this-field-matters">Why This Field Matters&lt;/h2>
&lt;p>In 2026, 22 professors from Stanford, Berkeley and Harvard moved to frontier AI labs: six to OpenAI, five to Anthropic, six to Meta, five to Google DeepMind, with five more announcing fall departures. At Harvard SEAS alone, 12 of 43 CS-affiliated tenure-track faculty currently hold or recently held an industry position.&lt;/p>
&lt;p>Pay is not the whole story. Training frontier models now takes GPU clusters costing hundreds of millions, which opened a physical gap between the experiments a university lab can run and the ones a frontier lab can run. For a researcher who wants to test a hypothesis at real scale, the option set narrowed. Compensation sits on top of that: senior researcher packages run at multiples of a tenured salary.&lt;/p></description></item><item><title>AI Drug Discovery Researcher: Where Machine Learning Meets the Lab Bench</title><link>https://reputo.net/en/jobs/researcher/specializations/ai-drug-discovery/</link><pubDate>Fri, 26 Jun 2026 00:00:00 +0000</pubDate><guid>https://reputo.net/en/jobs/researcher/specializations/ai-drug-discovery/</guid><description>&lt;h2 id="why-this-field-matters">Why This Field Matters&lt;/h2>
&lt;p>Bringing a single drug to market takes well over a decade and runs into the billions. Most of that bleeds out in the earliest stage, finding a molecule worth pursuing. Out of millions of candidates, a handful reach the clinic, and most of those still fail. Machine learning is rewriting that math. When DeepMind&amp;rsquo;s AlphaFold cracked the 50-year protein-folding problem in 2020, predicting a 3D structure from sequence alone in minutes, the old bottleneck, you need the structure before you can design the drug, simply dissolved.&lt;/p></description></item></channel></rss>